DE69203724D1 - Amidderivate vom Antibiotikum A 40926. - Google Patents

Amidderivate vom Antibiotikum A 40926.

Info

Publication number
DE69203724D1
DE69203724D1 DE69203724T DE69203724T DE69203724D1 DE 69203724 D1 DE69203724 D1 DE 69203724D1 DE 69203724 T DE69203724 T DE 69203724T DE 69203724 T DE69203724 T DE 69203724T DE 69203724 D1 DE69203724 D1 DE 69203724D1
Authority
DE
Germany
Prior art keywords
antibiotic
amide derivatives
alkylaminocarbonyl
substituent
staplylococci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69203724T
Other languages
English (en)
Other versions
DE69203724T2 (de
Inventor
Adriano Malabarba
Romeo Ciabatti
Gianbattista Panzone
Alessandra Marazzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicuron Pharmaceuticals LLC
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69203724(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE69203724D1 publication Critical patent/DE69203724D1/de
Application granted granted Critical
Publication of DE69203724T2 publication Critical patent/DE69203724T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69203724T 1991-07-29 1992-07-14 Amidderivate vom Antibiotikum A 40926. Expired - Fee Related DE69203724T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12
PCT/EP1992/001594 WO1993003060A1 (en) 1991-07-29 1992-07-14 Amide derivatives of antibiotic a 40926

Publications (2)

Publication Number Publication Date
DE69203724D1 true DE69203724D1 (de) 1995-08-31
DE69203724T2 DE69203724T2 (de) 1996-01-18

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69203724T Expired - Fee Related DE69203724T2 (de) 1991-07-29 1992-07-14 Amidderivate vom Antibiotikum A 40926.

Country Status (24)

Country Link
EP (2) EP0596929B1 (de)
JP (1) JP3418762B2 (de)
KR (1) KR100242682B1 (de)
AT (1) ATE125551T1 (de)
AU (1) AU666862B2 (de)
BG (1) BG61124B2 (de)
CA (1) CA2109601C (de)
CZ (1) CZ285703B6 (de)
DE (1) DE69203724T2 (de)
DK (1) DK0596929T3 (de)
ES (1) ES2075709T3 (de)
FI (1) FI112662B (de)
GR (1) GR3017897T3 (de)
HU (2) HU223946B1 (de)
IE (1) IE68420B1 (de)
IL (1) IL102623A (de)
MX (1) MX9204394A (de)
NO (1) NO314150B1 (de)
NZ (1) NZ243735A (de)
PL (1) PL171813B1 (de)
RU (1) RU2125058C1 (de)
TW (1) TW218021B (de)
UA (1) UA41283C2 (de)
WO (1) WO1993003060A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
TW457248B (en) * 1994-01-28 2001-10-01 Lilly Co Eli Glycopeptide antibiotic derivatives
KR100430202B1 (ko) * 1995-07-05 2004-09-18 아벤티스 벌크 에스.피.에이. 등전성 집속에 의한 달바 헵티드 항생제의 정제
WO1997040067A1 (en) * 1996-04-23 1997-10-30 Biosearch Italia S.P.A. Improved chemical process for preparing amide derivatives of antibiotic a 40926
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
SI1140993T1 (en) 1998-12-23 2003-12-31 Theravance, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
MY123217A (en) * 1998-12-23 2006-05-31 Theravance Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
WO2004045637A1 (en) 2002-11-18 2004-06-03 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1641480A1 (de) 2003-05-27 2006-04-05 Theravance, Inc. Verwendung eines antimykotischen polyen-makrolids in kombination mit einem antibakteriellen glycopeptid-mittel
EP1654036B1 (de) 2003-07-22 2007-12-26 Theravance, Inc. Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
BRPI0516657A (pt) 2004-11-29 2008-09-16 Univ Nagoya Nat Univ Corp derivados de monÈmero antibiótico de glicopeptìdeo
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
BRPI0821947A2 (pt) 2007-12-26 2015-09-22 Shionogi & Co derivados de antibiótico de glicopetídeo glicosilatado
CN116710470A (zh) * 2021-01-11 2023-09-05 埃克斯利亚制药有限公司 合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
DE68925806T2 (de) * 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
JPH06503306A (ja) * 1990-12-05 1994-04-14 グルポ・レペチツト・エス・ピー・エイ テイコプラニン抗生物質の３８−デカルボキシ−３８−ヒドロキシメチル誘導体およびそれらの製造方法
EP0578644B1 (de) * 1991-03-27 1996-12-04 GRUPPO LEPETIT S.p.A. Esterderivate von antibiotikum-a 40926

Also Published As

Publication number Publication date
BG61124B2 (bg) 1996-11-29
FI112662B (fi) 2003-12-31
JPH06509347A (ja) 1994-10-20
HUT66080A (en) 1994-09-28
WO1993003060A1 (en) 1993-02-18
RU2125058C1 (ru) 1999-01-20
FI940394A (fi) 1994-01-26
NO934722D0 (no) 1993-12-20
MX9204394A (es) 1993-01-29
TW218021B (de) 1993-12-21
AU2326292A (en) 1993-03-02
AU666862B2 (en) 1996-02-29
HU211347A9 (en) 1995-11-28
NO314150B1 (no) 2003-02-03
EP0596929A1 (de) 1994-05-18
HU223946B1 (hu) 2005-03-29
JP3418762B2 (ja) 2003-06-23
IE922451A1 (en) 1993-02-10
UA41283C2 (uk) 2001-09-17
IE68420B1 (en) 1996-06-12
CZ19294A3 (en) 1994-11-16
IL102623A (en) 1996-10-16
EP0525499A1 (de) 1993-02-03
CA2109601A1 (en) 1993-02-18
CA2109601C (en) 2002-07-02
IL102623A0 (en) 1993-01-14
GR3017897T3 (en) 1996-01-31
DK0596929T3 (da) 1995-09-11
HU9400256D0 (en) 1994-05-30
EP0596929B1 (de) 1995-07-26
KR100242682B1 (ko) 2000-02-01
FI940394A0 (fi) 1994-01-26
NZ243735A (en) 1995-01-27
ATE125551T1 (de) 1995-08-15
ES2075709T3 (es) 1995-10-01
NO934722L (no) 1994-02-14
PL171813B1 (pl) 1997-06-30
DE69203724T2 (de) 1996-01-18
CZ285703B6 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
DE69203724D1 (de) Amidderivate vom Antibiotikum A 40926.
ATE282630T1 (de) Dolastatin-derivate
ES2144421T3 (es) Nuevo derivado tetrapeptidico.
NO2006018I1 (no) Entekavir:(2-amino-1,9-dihydro-9Ä(1S,3R,4S)-4hydroksy-3-(hydroksymetyl)-2-metylencyklopentylÜ-6H-purin-6-on og hydrater derav, saerlig monohydrat
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
RU94013457A (ru) Амидные производные антибиотика а 40926
DE69835841D1 (de) Hydrazonderivate
BR9608873A (pt) Inibidores de selectina de moléculas pequenas di e trivalentes
ES2173391T3 (es) Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
ATE110382T1 (de) Oxetanocin.
DK0451547T3 (da) 1,4,8-triazacyclotridecanderivater med prolylendopeptidase inhiberende aktivitet
BG102647A (en) Acyclic nucleoside derivatives
ATE90685T1 (de) Disaccharidderivate.
FI963568A0 (fi) Peptidijohdannaisia
ES2064577T3 (es) N-azabiciclo(3.3.0)octanoamidas de acidos aromaticos.
DE69611148D1 (de) Pyrrolo(4,3,2-de)chinolin-Derivat
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
ES2068947T3 (es) Derivados de angolamicina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOSEARCH ITALIA S.P.A., GERENZANO, IT

8327 Change in the person/name/address of the patent owner

Owner name: VICURON PHARMACEUTTICALS INC.(N.D.GES.STAATES DELA

8328 Change in the person/name/address of the agent

Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539 M

8339 Ceased/non-payment of the annual fee